Skip to main content

EndSARS: Kingsley Moghalu advises Nigerian youth to get involved in politics

Prof. Kingsley Moghalu, a former presidential candidate in the 2019 general elections, has advised youth in the country to join politics.

Moghalu said he stands in solidarity with the youth in their calls for the end of police brutality and bad governance in the country.

The former Deputy Governor of the Central Bank of Nigeria, CBN, also decried the apparent impotence of Nigerian security agencies in the face of killer herdsmen and bandits and their quick response to quash peaceful protests.

The economist, however, pointed out that the #EndSARS protests, which Ordinarily represent a welcome awakening of Nigerian youth against bad governance, will not be enough to solve the problem of bad governance in the country.

He said that the best protest against underperforming governments in a democratic setting is the one at the ballot box, using the Permanent Voters Card (PVC).

In a statement he personally signed and made available to reporters in Abuja at the weekend, Moghalu noted that what Nigerians want at this point in time is a better governed country that creates real opportunities for our youth, who make up 65 percent of it’s population of 200 million.

The former Deputy CBN Governor said that the future of Nigeria is bleak if the current trends of rising poverty, low-skilled youth, a dysfunctional education system, and high youth unemployment are not reversed.

“These also are aspects of our fundamental dignity that the #EndSARS protests seek to assert. Only an active and structural engagement with democratic politics by Nigerian youth can achieve the goals of #EndSARS. Protest simply isn’t enough,” he said.

“I therefore call on Nigerian youth to focus their energy on: (1) strong advocacy and pressure to ensure that the National Assembly passes an electoral reform bill by mid-2021 that includes provisions for electronic transmissions of votes from polling units to the database of the Independent National Electoral Commission (INEC) and for Nigerians in diaspora to have the opportunity to vote from abroad; (2) voter registration en masse for the elections in 2023 and subsequent elections, and (3) structural participation in politics, i.e. joining political parties of their individual choice as members, voting, and standing as candidates in elections. All three approaches are essential. It is not enough to simply stand as candidates in the context of Not Too Young, which was nevertheless a commendable initiative,” he added.

The former presidential candidate warned that Nigerian youth are likely to get the same outcomes as the Arab Spring countries if they continue to shy away from politics on the basis of weak excuses such as: ‘our votes will not count’, ‘the elections will be rigged’, among others.

He noted that with these excuses, the youth are surrendering their future to corrupt, incompetent and repressive political leaders, insisting that this should not be an option for the youth in the country.

The post EndSARS: Kingsley Moghalu advises Nigerian youth to get involved in politics appeared first on Vanguard News.


by Emmanuel Okogba via Vanguard News https://ift.tt/3b0S0ug Best Known Member of the Cabinet Wikipedia
Labels:

Comments

Post a Comment

Popular posts from this blog

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO:  COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...
Post a Comment
Read more

Naomi Osaka’s statement about withdrawing from French Open

Japan’s Naomi Osaka returns the ball to Romania’s Patricia Maria Tig during their first round match of the French open tennis tournament at the Roland Garros stadium Sunday, May 30, 2021 in Paris. (AP Photo/Christophe Ena) Naomi Osaka tweeted the following statement announcing her withdrawal from the French Open on Monday: “Hey everyone, this isn’t a situation I ever imagined or intended when I posted a few days ago. I think now the best thing for the tournament, the other players and my well-being is that I withdraw so that everyone can get back to focusing on the tennis going on in Paris. ”I never wanted to be a distraction and I accept that my timing was not idea and my message could have been clearer. ”More importantly I would never trivialize mental health or use the term lightly. The truth is that I have suffered long bouts of depression since the US Open in 2018 and I have had a really hard time coping with that. Anyone that knows me knows I’m introverted, and anyone tha...
Post a Comment
Read more

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...
Post a Comment
Read more